Hält derzeit Positionen bei Oscient Pharmaceuticals Corp, Jazz Pharmaceuticals PLC and Aptinyx Inc
Position | Company | Period |
---|---|---|
Director | Oscient Pharmaceuticals Corp | 1. Januar 1999 - |
Independent Director | Jazz Pharmaceuticals PLC | 2. Mai 2013 - |
President, Chief Executive Officer, Director | Aptinyx Inc | 1. Juni 2015 - |
Independent Director | ARIAD Pharmaceuticals Inc | 28. April 2011 - 16. Februar 2017 |
Deputy Chairman of the Supervisory Board | Medigene AG | 27. Oktober 2003 - 16. Juli 2013 |
Corporate Vice President, Chief Scientific Officer | Baxter International Inc | 1. Mai 2001 - 1. Januar 2012 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-15 | 2023-08-14 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
1.241
-8.3%
138,16171.454 USD |
1.241 -8.3% | 138,16 | 171.454 USD | |
2022-08-09 | 2022-08-08 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
1.089
-8.4%
152,32165.877 USD |
1.089 -8.4% | 152,32 | 165.877 USD | |
2022-08-09 | 2022-08-05 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
8.000
-43.5%
155,871.246.920 USD |
8.000 -43.5% | 155,87 | 1.246.920 USD | |
2021-12-08 | 2021-12-06 |
Aptinyx Inc
(APTX)
|
K Kauf |
100.000
+inf%
2,23223.000 USD |
100.000 +inf% | 2,23 | 223.000 USD | |
2020-08-10 | 2020-08-07 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
931
-9.0%
125,87117.186 USD |
931 -9.0% | 125,87 | 117.186 USD | |
2020-01-14 | 2020-01-10 |
Aptinyx Inc
(APTX)
|
K Kauf |
35.000
+inf%
3,00105.000 USD |
35.000 +inf% | 3,00 | 105.000 USD | |
2018-08-13 | 2018-08-10 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
660
-9.2%
176,61116.563 USD |
660 -9.2% | 176,61 | 116.563 USD | |
2016-08-17 | 2016-08-15 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
633
-11.3%
136,4586.373 USD |
633 -11.3% | 136,45 | 86.373 USD | |
2016-05-17 | 2016-05-16 |
Jazz Pharmaceuticals PLC
(JAZZ)
|
V Verkauf |
644
-13.2%
145,2093.509 USD |
644 -13.2% | 145,20 | 93.509 USD |